Krsnaa Diagnostics Limited - healthcare in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN L74900PN2010PLC138068 Incorporated 22 December 2010 ROC Pune HQ Pune, Maharashtra, India
Active Listed - NSE: KRSNAA · BSE: 543328 Public Limited Company healthcare
Data last updated
Market Cap
₹1,788 Cr
KRSNAA · NSE
Share Price
₹548.45
-0.51% today
Revenue
₹773 Cr
FY 2025-26 · +5.2% YoY
EBITDA
₹212 Cr
Margin 27.4%
Net Profit
₹101 Cr
FY 2025-26 · +36.8% YoY
P/E (TTM)
18.6x
P/B 1.9x

About Krsnaa Diagnostics Limited

Data last updated: 26 September 2026

Krsnaa Diagnostics Limited is a public limited company based in Pune, Maharashtra, India. It specialises in other hospital and medical care activities, a part of the broader healthcare sector. Incorporated on 22 December 2010, the company has been in operation for over 16 years.

Registered with ROC Pune under CIN L74900PN2010PLC138068. Listed on BSE: 543328 and NSE: KRSNAA.

Capital: an authorised share capital of ₹147.16 Cr and a paid-up capital of ₹16.22 Cr. Formerly known as Krsnaa Diagnostics Private Limited and Krsna Diagnostics Private Limited. It is led by directors including Adesh Kumar Gupta and Rajendra Khivraj Mutha.

Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Pune, Maharashtra.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹772.77 Cr, a growth of 6.79% compared to the previous year. The net worth stands at ₹980.39 Cr (up 11.06% YoY). Total assets are valued at ₹1,584.52 Cr (up 42.75% YoY).

The company has a workforce of approximately 3,582 employees as per the latest available data. Its group structure includes 7 subsidiaries.

The company is associated with 1 brand - Krsnaa Diagnostics. As per MCA filings, the company has open charges of ₹832.76 Cr and satisfied charges of ₹388.35 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website krsnaa.in.

Company Details of Krsnaa Diagnostics Limited
CIN L74900PN2010PLC138068
Registration Number 138068
Incorporation Date 22 December 2010
ROC Pune
Listing Status Listed (BSE: 543328, NSE: KRSNAA)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Apps
  • Registered Address
    S. No. 243/A Hissa No. 6 Cts No. 4519 4519/1 Near Chinchwad Station Chinchwad Taluk, A – Haveli, Pune, Maharashtra, India – 411019
  • Industry
    Healthcare, Other Hospital And Medical Care Activities
Company report
Krsnaa Diagnostics Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Krsnaa Diagnostics Limited report

Financials, compliance, directors, charges, ownership and filings for Krsnaa Diagnostics Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited has undergone 2 name changes throughout its history. The company was previously known as Krsnaa Diagnostics Private Limited, and Krsna Diagnostics Private Limited. The current legal name is Krsnaa Diagnostics Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Krsnaa Diagnostics Limited Current
Krsnaa Diagnostics Private Limited Previous
Krsna Diagnostics Private Limited Previous

CIN History of Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74900PN2010PLC138068, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L74900PN2010PLC138068 Current
U74900PN2010PTC138068 Previous
U74900PN2010PLC138068 Previous

Associated Brands with Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited operates one associated brand: Krsnaa Diagnostics. These brands represent Krsnaa Diagnostics Limited's diversified market presence and brand portfolio.

Brand Description Website
Chain of radiology & pathology laboratory centers krsnaadiagnostics.com

Competitors & Alternatives of Krsnaa Diagnostics Limited

Brands and companies operating in the same space as Krsnaa Diagnostics Limited include Thyrocare, Suraksha Diagnostics, Vijaya Diagnostic Centre and 6 more.

Competitor Description Location Founded
Thyrocare Thyrocare Diagnostic testing centers for pathology and health screenings are operated. Mumbai, India, India 1996
Suraksha Diagnostics Suraksha Diagnostics Pathology, molecular diagnostics, and imaging services are provided. Kolkata, India, India 2005
Vijaya Diagnostic Centre Vijaya Diagnostic Centre Diagnostic services are offered via a chain of centers. Hyderabad, India, India 1981
Igenetic Igenetic Provider molecular diagnostic solutions and services Mumbai, India, India 2013
Health Ledger Health Ledger Chain of radiology & pathology laboratory centers Pune, India, India 2020
GD GD A chain of clinical laboratories is operated for diagnostic services. Mumbai, India, India 2007
Aarthi Scans Aarthi Scans Chain of diagnostic centers Chennai, India, India 2000
Medall Medall Medical diagnostic services are provided through a chain of centres. Chennai, India, India 2008
SONOSCAN SONOSCAN Offers blood tests, radiology, home collection, and online booking services. Kolkata, India, India 1990

Business Activity of Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q6 Other Hospital and Medical Care Activities Locked
Premium access

Business activity turnover details for Krsnaa Diagnostics Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited is audited by MS K A & Associates for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
MS K A & Associates Locked Locked Locked
Premium access

Complete auditor history for Krsnaa Diagnostics Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited is currently managed by 7 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Adesh Kumar Gupta Director 28 May 2022 4 Years 3 Months Current
Rajendra Khivraj Mutha Whole-Time Director 22 Dec 2010 15 Years 9 Months Current
Chetan Rameshchandra Desai Director 25 Apr 2021 5 Years 5 Months Current
Prem Pradeep Nominee Director 08 Oct 2020 5 Years 11 Months Current
Yash Prithviraj Mutha Managing Director 31 Jan 2019 7 Years 7 Months Current
Raju Venkatraman Additional Director 25 Apr 2026 0 Years 5 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Krsnaa Diagnostics Limited FY 2025-26 filings available

Krsnaa Diagnostics Limited reported revenue of ₹772.77 Cr (up 6.79% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹773 Cr
+6.8% YoY
EBITDA
₹212 Cr
+11.4% YoY
Profit After Tax
₹101 Cr
+36.8% YoY
Net Worth
₹980 Cr
+11.1% YoY
Total Assets
₹1,585 Cr
+42.8% YoY
Total Debt
₹534 Cr
+162.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Income statement
Revenue77372462548745561.0239.14
Revenue growth+5.2%+11.0%+31.8%+12.6%+663.9%+40.1%+9997.0%
EBITDA21219014412213118.618.87
EBITDA margin+27.4%+26.3%+23.1%+25.1%+28.9%+30.5%+22.7%
Profit before tax13010370.0080.2086.500.09(3.29)
Net profit10174.1356.8761.9768.58(0.09)(4.88)
Net profit margin+13.1%+10.2%+9.1%+12.7%+15.1%-0.2%-12.5%
EPS (₹)30.8824.0317.6019.7821.780.000.00
Balance sheet
Total assets1,5851,110992806755155160
Net worth98088381073968475.7260.92
Total debt53420416032.4840.9936.7880.97
Cash & bank36168.441751092427.2037.72
Net working capital529265258132221(11.67)30.35
Cash flow
Cash from operations14387.3324.3576.3012864.02(22.55)
Cash from investing(396)(99.61)(129)(109)(241)(53.98)(46.53)
Cash from financing27913.7584.19(33.15)176(40.57)105
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue236193181206193186175186
Revenue growth (YoY)+22.1%+3.5%+3.8%+10.6%+13.4%+11.9%+10.2%+19.9%
Other income7.2531.503.774.183.964.399.244.59
EBITDA57.9854.8746.3659.1551.4052.9945.0749.40
EBITDA margin+24.6%+28.5%+25.6%+28.7%+26.6%+28.5%+25.8%+26.5%
Depreciation27.9622.5922.6623.5921.6321.9622.7022.20
Interest14.8312.087.798.196.306.816.136.39
Profit before tax22.4451.7019.6831.5527.4328.6125.4825.40
Tax5.889.994.447.626.907.936.075.81
Net profit16.5641.7115.2423.9320.5320.6819.4119.59
EPS (₹)5.0412.704.667.256.256.285.885.92
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue691686594464455396258
Revenue growth-2.2%+9.1%+31.9%+6.1%+5.9%-18.8%+327.6%
EBITDA21319714612413593.81(114)
EBITDA margin+30.8%+28.7%+24.6%+26.8%+29.6%+23.7%-44.2%
Profit before tax13211071.9482.1989.59295(158)
Net profit10379.3358.6063.3770.89185(112)
Net profit margin+14.9%+11.6%+9.9%+13.7%+15.6%+46.7%-43.3%
EPS (₹)31.2625.6518.1420.2322.52284.73(216.83)
Balance sheet
Total assets1,5901,118997810758474558
Net worth992893815742687232(197)
Total debt53120216032.4840.99232231
Cash & bank35667.91175108242153127
Net working capital546276264137224128141
Cash flow
Cash from operations13489.3824.3975.4812911937.81
Cash from investing(391)(102)(129)(109)(241)(67.37)(76.65)
Cash from financing27813.9184.21(33.13)17620.035.78
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue211173159183176175165179
Revenue growth (YoY)+20.0%-0.9%-3.5%+2.3%+7.6%+9.6%+9.0%+21.7%
Other income7.2131.413.804.214.004.469.294.60
Total expenses154116112125126121117126
EBITDA56.7356.8347.6758.0050.1053.3047.9052.48
EBITDA margin+26.9%+32.8%+29.9%+31.7%+28.5%+30.5%+29.0%+29.4%
Depreciation27.7022.2522.5323.4721.5121.8022.6922.20
Interest14.7211.867.728.126.256.756.136.39
Profit before tax21.5254.1321.2230.6226.3429.2128.3728.49
Tax5.7010.754.737.406.788.156.776.53

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 26 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue236193181206193186175186
Revenue growth (YoY)+22.1%+3.5%+3.8%+10.6%+13.4%+11.9%+10.2%+19.9%
Other income7.2531.503.774.183.964.399.244.59
EBITDA57.9854.8746.3659.1551.4052.9945.0749.40
EBITDA margin+24.6%+28.5%+25.6%+28.7%+26.6%+28.5%+25.8%+26.5%
Depreciation27.9622.5922.6623.5921.6321.9622.7022.20
Interest14.8312.087.798.196.306.816.136.39
Profit before tax22.4451.7019.6831.5527.4328.6125.4825.40
Tax5.889.994.447.626.907.936.075.81
Net profit16.5641.7115.2423.9320.5320.6819.4119.59
EPS (₹)5.0412.704.667.256.256.285.885.92
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Revenue77372462548745561.0239.14
Revenue growth+5.2%+11.0%+31.8%+12.6%+663.9%+40.1%+9997.0%
Other income43.3925.5416.8019.3814.912.343.23
Total expenses56153448136532442.4130.27
Employee cost0.0013711174.5654.1512.509.00
EBITDA21219014412213118.618.87
EBITDA margin+27.4%+26.3%+23.1%+25.1%+28.9%+30.5%+22.7%
Depreciation90.4688.3274.5553.7841.3911.586.44
Interest34.3624.6516.497.7018.499.288.95
Profit before tax13010370.0080.2086.500.09(3.29)
Tax28.9325.0813.1718.0918.120.181.61
Net profit10174.1356.8761.9768.58(0.09)(4.88)
Net profit margin+13.1%+10.2%+9.1%+12.7%+15.1%-0.2%-12.5%
EPS (₹)30.8824.0317.6019.7821.780.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Equity & liabilities
Share capital16.2216.1516.1515.7015.7070.1555.12
Reserves & surplus9648677947236695.575.80
Shareholders' funds (net worth)98088381073968475.7260.92
Minority interest0.000.000.000.000.000.000.00
Secured loans47926.9711.0016.5025.6332.3878.55
Unsecured loans55.1117714915.9815.364.402.42
Total debt53420416032.4840.9936.7880.97
Total liabilities1,5851,110992806755155160
Assets
Gross block1,04297187462749116091.54
Net block65667064747138613174.02
Capital work in progress2082.969.8525.4828.265.7820.05
Investments57.4331.540.290.290.290.570.53
Inventories26.6629.4835.8125.079.170.950.67
Sundry debtors29627817673.1057.8714.118.44
Cash & bank balances36168.441751092427.2037.72
Loans & advances55.4638.8233.9015.9525.223.369.38
Total current assets73841442122333425.6256.21
Total current liabilities20914916490.9911337.2925.86
Net working capital529265258132221(11.67)30.35
Total assets1,5851,110992806755155160
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Opening cash3.852.3822.7288.4524.6837.721.40
Net cash from operating activities14387.3324.3576.3012864.02(22.55)
Net cash from investing activities(396)(99.61)(129)(109)(241)(53.98)(46.53)
Net cash from financing activities27913.7584.19(33.15)176(40.57)105
Net change in cash26.381.47(20.35)(65.73)63.78(30.53)36.33
Closing cash36168.441751092427.2037.72
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Growth
Sales growth+6.8%+15.8%+28.3%+7.0%+646.4%+55.9%+9997.0%
EBITDA growth+11.4%+31.8%+17.9%-7.0%+606.5%+109.8%+9997.0%
PBT growth+27.0%+46.7%-12.7%-7.3%-+9998.0%+9997.0%
Net income growth+36.8%+30.4%-8.2%-9.6%+9998.0%+98.2%+9997.0%
Revenue CAGR (3Y)+16.6%+16.7%+117.2%+131.7%---
EBITDA CAGR (3Y)+20.1%+13.1%+97.9%+139.8%---
Profitability & leverage
Net income margin+13.1%+10.7%+9.1%+12.8%+15.0%-0.2%-12.5%
Return on capital employed-+12.1%+9.6%+11.3%+13.9%0.0%0.0%
Return on net worth-+9.2%+7.3%+8.7%+10.0%0.0%0.0%
Debt / equity-0.210.120.050.060.861.33
Long-term debt / equity-0.050.040.040.050.390.53
Interest cover28.3224.2123.6611.2420.53132.01368.31
Efficiency & per share
Fixed asset turnover-0.780.830.870.930.490.43
Inventory turnover-22.1720.5428.4549.6775.3358.42
Debtors turnover-3.195.017.447.875.414.64
EPS (₹)30.8824.0317.6019.7821.780.000.00
Dividend per share (₹)2.002.752.502.752.500.000.00
Book value per share (₹)0.00273.39250.79235.28217.9820.7921.24
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue211173159183176175165179
Revenue growth (YoY)+20.0%-0.9%-3.5%+2.3%+7.6%+9.6%+9.0%+21.7%
Other income7.2131.413.804.214.004.469.294.60
Total expenses154116112125126121117126
EBITDA56.7356.8347.6758.0050.1053.3047.9052.48
EBITDA margin+26.9%+32.8%+29.9%+31.7%+28.5%+30.5%+29.0%+29.4%
Depreciation27.7022.2522.5323.4721.5121.8022.6922.20
Interest14.7211.867.728.126.256.756.136.39
Profit before tax21.5254.1321.2230.6226.3429.2128.3728.49
Tax5.7010.754.737.406.788.156.776.53
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue691686594464455396258
Revenue growth-2.2%+9.1%+31.9%+6.1%+5.9%-18.8%+327.6%
Other income43.4125.6716.8019.4114.9326512.95
Total expenses478489448340320303373
Employee cost0.0011297.5765.6352.7429.9123.13
EBITDA21319714612413593.81(114)
EBITDA margin+30.8%+28.7%+24.6%+26.8%+29.6%+23.7%-44.2%
Depreciation89.7688.1674.5553.7841.3937.4432.41
Interest33.9424.5716.477.6818.4925.9424.66
Profit before tax13211071.9482.1989.59295(158)
Tax29.6526.7913.3818.6818.90111(46.38)
Net profit10379.3358.6063.3770.89185(112)
Net profit margin+14.9%+11.6%+9.9%+13.7%+15.6%+46.7%-43.3%
EPS (₹)31.2625.6518.1420.2322.52284.73(216.83)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital16.2216.1516.1515.7015.7024920.19
Reserves & surplus967871797724671(17.02)(217)
Shareholders' funds (net worth)992893815742687232(197)
Secured loans49116610716.5025.63213229
Unsecured loans40.6336.0853.0715.9815.3618.752.20
Total debt53120216032.4840.99232231
Total liabilities1,5901,118997810758474558
Assets
Gross block1,036968874627491377308
Net block651668647471386309275
Capital work in progress2082.969.8525.4828.263.729.13
Investments57.5031.620.360.360.360.290.29
Inventories25.6629.4835.8125.079.177.215.07
Sundry debtors30828317874.5559.3175.2961.43
Cash & bank balances35667.91175108242153127
Loans & advances54.6838.5633.8615.9225.5317.4719.85
Total current assets744419422224336253214
Total current liabilities19814315887.0511212572.26
Net working capital546276264137224128141
Total assets1,5901,118997810758474558
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash3.321.8622.1388.3224.68(46.65)(14.52)
Net cash from operating activities13489.3824.3975.4812911937.81
Net cash from investing activities(391)(102)(129)(109)(241)(67.37)(76.65)
Net cash from financing activities27813.9184.21(33.13)17620.035.78
Net change in cash21.731.46(20.27)(66.19)63.6571.32(33.06)
Closing cash25.0567.91175108242153127
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+0.8%+15.4%+28.1%+2.0%+14.7%+53.4%+75.9%
EBITDA growth+8.1%+34.6%+17.6%-7.7%+43.4%+9998.0%-
PBT growth+20.7%+52.4%-12.5%-8.3%-69.7%+9998.0%-
Net income growth+29.4%+35.4%-7.5%-10.6%-61.7%+9998.0%-
Revenue CAGR (3Y)+14.2%+14.7%+14.5%+21.6%+45.8%+91.0%+93.6%
EBITDA CAGR (3Y)+19.6%+13.5%+15.9%-+31.1%+86.3%-
Profitability & leverage
Net income margin+14.9%+12.1%+9.9%+13.7%+15.5%+46.6%-43.3%
Return on capital employed-+12.7%+9.8%+11.5%+17.0%+59.9%0.0%
Return on net worth-+9.7%+7.5%+8.9%+19.7%-204.0%0.0%
Debt / equity-0.210.120.050.3013.270.00
Long-term debt / equity-0.050.040.040.228.800.00
Interest cover27.6322.6523.0010.9019.8546.02-16.82
Efficiency & per share
Fixed asset turnover-0.740.790.831.051.160.87
Inventory turnover-21.0119.5327.1155.5464.5755.70
Debtors turnover-2.974.716.936.765.804.39
EPS (₹)31.2625.6518.1420.2322.52284.73(216.83)
Dividend per share (₹)2.002.752.502.752.500.000.00
Book value per share (₹)0.00274.65251.73235.63218.72(16.20)(410.62)
Want more history and ratios?
You're viewing the latest exchange-filed financials for Krsnaa Diagnostics Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Krsnaa Diagnostics Limited

As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 27.10%, foreign institutional investors hold 4.30%, domestic institutional investors hold 14.50%, retail and other public shareholders hold 54.10% of Krsnaa Diagnostics Limited.

Promoters: 27.10%DII (Domestic Institutional): 14.50%FII (Foreign Institutional): 4.30%Retail & Others: 54.10%
Jun 2026
QUARTER
27.10% Promoters
14.50% DII (Domestic Institutional)
4.30% FII (Foreign Institutional)
54.10% Retail & Others
Promoter holding - history
Now 27.10% · Jun 2026High 27.10% · Sep 2025Low 27.10% · Sep 2025
26%26.8%27.5%28.3%29%Sep 2025Dec 2025Mar 2026Jun 2026Sep 2025: 27.10%Dec 2025: 27.10%Mar 2026: 27.10%Jun 2026: 27.10%27.10%27.10%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025
Promoters27.10%27.10%27.10%27.10%
Public72.90%72.90%72.90%72.90%

Group Structure of Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited has 7 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Krsnaa Diagnostics Limited's business expansion strategy and organizational complexity.

7
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Kdpl Diagnostics (Ludhiana) Private Limited U85100PN2021PTC199690 -
Kdpl Diagnostics (Amritsar) Private Limited U85100PN2021PTC199780 -
Kdpl Diagnostics (Bathinda) Private Limited U85100PN2021PTC199781 -
Kdpl Diagnostics (Jalandhar) Private Limited U85100PN2021PTC199783 -
Kdpl Diagnostics (Patiala) Private Limited U85100PN2021PTC199785 -
Kdpl Diagnostics (Sas Nagar) Private Limited U85110PN2021PTC199787 -

Showing major subsidiaries. Total: 7.

Charges & Borrowings of Krsnaa Diagnostics Limited

Open charges
₹832.76 Cr
Satisfied charges
₹388.35 Cr
Breakdown by lending institutions
Others₹689.00 Cr
Hdfc Bank Limited₹120.00 Cr
Yes Bank Limited₹23.75 Cr
Punjab National Bank₹0.01 Cr
Latest charge details
DateLenderAmountStatus
12 Jan 2026 Others ₹430 Cr Open
20 Sep 2025 Others ₹50 Cr Open
11 Nov 2024 Hdfc Bank Limited ₹120 Cr Open
08 Aug 2024 Others ₹20 Cr Open
21 Feb 2024 Yes Bank Limited ₹23.75 Cr Open

Total charge records: 48 View all charges

Employees and EPFO Compliance at Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited has a workforce of 3,582 employees as of Aug 02, 2025.

Employee count
3,582
Active EPFO establishments
1
Employee growth
6.45%
Premium access

Employee and EPFO history for Krsnaa Diagnostics Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Krsnaa Diagnostics Limited

Premium access

GST registrations and filing compliance for Krsnaa Diagnostics Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Krsnaa Diagnostics Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Krsnaa Diagnostics Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Krsnaa Diagnostics Limited

Premium access

MSME payment history for Krsnaa Diagnostics Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Krsnaa Diagnostics Limited

Premium access

Corporate group structure for Krsnaa Diagnostics Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Krsnaa Diagnostics Limited

Premium access

MCA filings and documents for Krsnaa Diagnostics Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Krsnaa Diagnostics Limited

Directors
16 May 2026
Chandra Prakash Singh was appointed as a Cfo on 16 May 2026 & has been associated with this company since 4 months 14 days.
Directors
25 Apr 2026
Raju Venkatraman was appointed as a Additional Director on 25 Apr 2026 & has been associated with this company since 5 months 4 days.
Directors
25 Apr 2026
Lilian Jessie Paul was appointed as a Additional Director on 25 Apr 2026 & has been associated with this company since 5 months 4 days.
Charges
12 Jan 2026
A charge with Others amounted to Rs. 430.00 Cr with Charge ID 101220230 was registered on 12 Jan 2026.
Charges
08 Oct 2025
A charge with Hdfc Bank Limited of Rs. 120.00 Cr registered on 11 Nov 2024 with Charge ID 101007094 was modified on 08 Oct 2025.
Activity
25 Sep 2025
Krsnaa Diagnostics Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.

Frequently Asked Questions about Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited is an active public limited company in the healthcare sector based in Pune, Maharashtra, India. It was incorporated on 22 December 2010 (16+ years old) and is registered under CIN L74900PN2010PLC138068. Listed on BSE: 543328 and NSE: KRSNAA. The company has 3,582 employees.

Krsnaa Diagnostics Limited reported revenue of ₹772.77 Cr for FY 2025-26 (up 6.79% YoY) based on consolidated financials.

The current directors of Krsnaa Diagnostics Limited are:

The primary industry of Krsnaa Diagnostics Limited is healthcare. The company specifically operates in other hospital and medical care activities. The company is currently active in this sector.

Yes. Krsnaa Diagnostics Limited is listed on both BSE (code: 543328) and NSE (symbol: KRSNAA).

Krsnaa Diagnostics Limited can be reached at the registered office: S. No. 243A Hissa No. 6 Cts No. 4519 45191 Near Chinchwad Station Chinchwad Taluk, A – Haveli, Pune, Maharashtra, India – 411019, or through the website krsnaa.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available